300 seed biotech investors
We list 300 seed biotech investors as of November 2026: 161 have an SEC filing on file and 139 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (65), New York (14) and Massachusetts (14).
Top 5 seed biotech investors, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Hatteras Venture Partners
Type: VC firm · HQ: Durham, NC · Stages: Seed · Focus: Biotech, Healthtech, Medtech · Latest activity: New fund, Oct 2026 · Fund size on file: $250M (SEC Form D, 2023)
Latest fund filing dated Oct 2026; $250M fund on file (SEC Form D, 2023); 62% of its observed portfolio is biotech and life sciences; backs seed; 8 named decision-makers on file.
ARCH Venture Partners
Type: VC firm · HQ: Chicago, IL · Stages: Pre-seed, Seed · Focus: Biotech, Healthtech, Deep Tech · Latest activity: New fund, Aug 2026 · Fund size on file: $3.0B (SEC Form D, 2024)
Latest fund filing dated Aug 2026; $3.0B fund on file (SEC Form D, 2024); 81% of its observed portfolio is biotech and life sciences; backs pre-seed, seed; 8 named decision-makers on file.
Future Ventures
Type: VC firm · HQ: Los Altos, CA · Stages: Seed · Focus: Biotech, Healthtech, AI, Energy · Latest activity: New fund, Oct 2026 · Fund size on file: $200M (SEC Form D, 2021)
Latest fund filing dated Oct 2026; $200M fund on file (SEC Form D, 2021); 38% of its observed portfolio is biotech and life sciences; backs seed; 4 named decision-makers on file.
Cambridge Innovation Capital
Type: VC firm · HQ: Cambridge, United Kingdom · Stages: Seed, Series A, Growth · Focus: Biotech, Healthtech, AI, Fintech · Latest activity: New fund, Oct 2026 · Fund size or assets: £600M (own site)
Latest fund filing dated Oct 2026; £600M on file (own site); 53% of its observed portfolio is biotech and life sciences; backs seed, Series A, growth-stage; 8 named decision-makers on file.
Breakout Ventures
Type: VC firm · HQ: San Francisco, CA · Stages: Seed · Focus: Biotech, AI, Healthtech, Industrial Tech · Latest activity: New deal, Jun 2026 · Fund size on file: $112M (SEC Form D, 2021)
Dated new deal in Jun 2026; $112M fund on file (SEC Form D, 2021); 50% of its observed portfolio is biotech and life sciences; backs seed; 6 named decision-makers on file.
First 25 of 300 seed biotech investors
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Biotech, Healthtech, Medtech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| ARCH Venture Partners | VC firm | Chicago, IL | Pre-seed, Seed | Biotech, Healthtech, Deep Tech | New fund, Aug 2026 | $3.0B (SEC Form D, 2024) | 4 Nov 2026 | 8 names · Unlock |
| Future Ventures | VC firm | Los Altos, CA | Seed | Biotech, Healthtech, AI, Energy | New fund, Oct 2026 | $200M (SEC Form D, 2021) | 4 Nov 2026 | 4 names · Unlock |
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Breakout Ventures | VC firm | San Francisco, CA | Seed | Biotech, AI, Healthtech, Industrial Tech | New deal, Jun 2026 | $112M (SEC Form D, 2021) | 4 Nov 2026 | 6 names, firm email · Unlock |
| Digitalis Ventures | VC firm | New York, NY | Seed | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Biotech, Healthtech, Medtech | Portfolio news, Oct 2026 | €425M (own site) | 7 Nov 2026 | 2 names, firm email · Unlock |
| Gore Range Capital | VC firm | Southlake, TX | Seed | Biotech, Healthtech, Medtech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 4 Nov 2026 | 1 name, firm email · Unlock |
| Aisling Capital | VC firm | New York, NY | Seed | Biotech, Healthtech, Food and Beverage, Medtech | Portfolio news, Jul 2026 | $64M (SEC Form ADV) | 5 Nov 2026 | 8 names · Unlock |
| First In Ventures | VC firm | Hobe Sound, FL | Pre-seed, Seed | Biotech, Healthtech, AI, Climate Tech | New fund, Sep 2026 | $22M (SEC Form D, 2026) | 4 Nov 2026 | 5 names, firm email · Unlock |
| Cambridge Angels | Angel network | Cambridge, United Kingdom | Seed | Biotech, Healthtech, Deep Tech, AI | Portfolio news, Oct 2026 | £400M (own site) | 4 Nov 2026 | LinkedIn page · Unlock |
| Narya | VC firm | Columbus, OH | Seed | Biotech, Fintech, Healthtech, Defense Tech | New fund, Sep 2026 | $200M (SEC Form D, 2026) | 4 Nov 2026 | 1 name · Unlock |
| Thirdrockventures | VC firm | Boston, MA | Pre-seed, Seed | Biotech, Healthtech, Medtech | New fund, Jun 2026 | $1.1B (SEC Form D, 2022) | 4 Nov 2026 | 8 names · Unlock |
| Two Bear Capital | VC firm | Whitefish, MT | Seed | Biotech, Healthtech, AI, Deep Tech | New fund, May 2026 | $123M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| Rapha Capital Management, LLC | VC firm | Surfside, FL | Seed | Biotech, Healthtech, Medtech | New deal, Jun 2026 | $10M (SEC Form D, 2021) | 5 Nov 2026 | 1 name · Unlock |
| Safar Partners | VC firm | Cambridge, MA | Seed | Biotech, Healthtech, Industrial Tech, Deep Tech | New deal, Aug 2026 | $300M (SEC Form D, 2023) | 4 Nov 2026 | 3 names, firm email · Unlock |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Biotech, AI, Developer Tools, Healthtech | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 5 Nov 2026 | 8 names · Unlock |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Biotech, Healthtech, Medtech | New fund, Sep 2026 | €300M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Start Codon | Accelerator | Cambridge, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI | Portfolio news, Nov 2026 | 4 Nov 2026 | 4 names, firm email · Unlock | |
| Angelor | VC firm | Lyon, France | Seed, Series A | Biotech, Healthtech, Medtech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name · Unlock |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 5 Nov 2026 | 6 names, firm email · Unlock |
| NSV | VC firm | Greenwich, CT | Seed, Late stage | Biotech, Healthtech, AI, Semiconductor | Portfolio news, Oct 2026 | $990M (SEC Form ADV) | 5 Nov 2026 | 5 names · Unlock |
| Epidarex Capital | VC firm | Edinburgh, United Kingdom | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Jul 2026 | $17M (SEC Form ADV) | 4 Nov 2026 | 8 names, firm email · Unlock |
| XISTA Science Ventures | VC firm | Klosterneuburg, Austria | Pre-seed, Seed | Biotech, Deep Tech, AI, Industrial Tech | Portfolio news, Oct 2026 | €96M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Biotech, Medtech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 7 Nov 2026 | No contact on file |
You are seeing 25 of 300. The full list adds 275 more investors and 1,458 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 300 break down
By region
| Region | On this list | Share |
|---|---|---|
| United States | 159 | 53% |
| United Kingdom | 75 | 25% |
| Europe | 65 | 22% |
By US state
| US state | On this list | Share |
|---|---|---|
| California | 65 | 22% |
| New York | 14 | 5% |
| Massachusetts | 14 | 5% |
| Texas | 13 | 4% |
| Florida | 10 | 3% |
| Illinois | 3 | 1% |
| Washington | 3 | 1% |
| New Jersey | 3 | 1% |
| Iowa | 3 | 1% |
| Pennsylvania | 3 | 1% |
By European country
| European country | On this list | Share |
|---|---|---|
| France | 13 | 4% |
| Netherlands | 9 | 3% |
| Spain | 9 | 3% |
| Germany | 8 | 3% |
| Austria | 4 | 1% |
| Sweden | 4 | 1% |
| Italy | 3 | 1% |
| Norway | 3 | 1% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 243 | 81% |
| Angel network | 18 | 6% |
| Government or university fund | 13 | 4% |
| Fund manager | 9 | 3% |
| SEIS/EIS fund | 8 | 3% |
| Accelerator | 4 | 1% |
Method and limits
- Source
- 161 of the 300 rows carry an SEC filing (Form D or Form ADV). All 300 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at seed.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 300 rows: stage 300, sector 300, fund size 194, website 300. In the paid file: named decision-makers on 279 rows, firm email on 147, LinkedIn page on 195, check size on 74.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many seed biotech investors are there?
We list 300 as of November 2026. 148 of the 300 have a fund filing or a dated deal in the last 12 months.
Which seed biotech investors raised a new fund in the last 12 months?
61 of the 300 have a fund filing dated in the last 12 months. The most recent on this list are Future Ventures (Oct 2026), Draper Associates (Oct 2026) and Pear Ventures (Oct 2026).
What is the typical fund size of seed biotech investors?
The median fund size on file for this list is $71M, across the 112 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 188 do not disclose a size there.
How do I contact seed biotech investors?
The paid file holds 1,458 named decision-makers across 279 of these 300 and a firm email for 147. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on seed biotech investors come from?
161 of the 300 rows have an SEC filing on file (Form D or Form ADV) and 139 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Broader lists
Narrower lists
Related lists
Seed AI investors (1,082)Seed SaaS investors (1,010)Seed healthtech investors (800)Seed fintech investors (584)Seed deep tech investors (555)Seed climate tech investors (458)Seed consumer investors (331)Seed B2B investors (302)Seed medtech investors (278)Seed energy investors (261)Seed industrial tech investors (249)Seed hardware investors (225)Seed cybersecurity investors (205)Series A biotech investors (153)Seed robotics investors (153)Pre-seed biotech investors (148)Seed developer tools investors (140)Seed media investors (125)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to biotech and life sciences and seed. Guide: how many investors to pitch. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.